---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-280509"
form_type: "8-K"
ticker: "SLNO"
cik: "0001484565"
company_name: "SOLENO THERAPEUTICS INC"
filed_at: "2024-12-17T23:59:59+00:00"
generated_at: "2026-05-29T02:21:47.936029+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Soleno Therapeutics secures up to $200M debt financing from Oxford Finance; initial $50M drawn

## Summary
- Initial $50 million draw at closing; up to $100 million in milestone tranches tied to FDA approval of DCCR for PWS.
- Pro-forma cash, equivalents and marketable securities of $334.7 million as of September 30, 2024 including the draw.
- Loan terms: 48-month interest-only period, 60-month maturity (extendable 12 months), floating rate of 1-month SOFR + 5.50%.
- Proceeds to support commercial launch activities for DCCR (diazoxide choline) extended-release tablets for Prader-Willi syndrome.
- Covenants include minimum cash (starting June 30, 2025) and revenue triggers; loan secured by substantially all assets including IP.

## SEC filing metadata
- accession: 0001193125-24-280509
- form_type: 8-K
- ticker: SLNO
- cik: 0001484565
- company_name: SOLENO THERAPEUTICS INC
- filed_at: 2024-12-17T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484565/000119312524280509/0001193125-24-280509-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484565/000119312524280509/d903020d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-280509
- JSON: https://secwatch.observer/filing/0001193125-24-280509.json
- Plain text: https://secwatch.observer/filing/0001193125-24-280509.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.